Oral pazopanib improves sight in macular degeneration cases
(HealthDay)—Oral pazopanib is well tolerated and improves mean best-corrected visual acuity, central retinal lesion thickness, and central retinal thickness at day 29 in a small, per-protocol, non-rescued population of ...
Oct 11, 2013
0
0